The global molecular diagnostic market size is projected to increase from USD 368.53 million in 2025 and is estimated to be worth around USD 542.97 m ...

QIAGEN N.V. today announced a series of product and partnership updates designed to strengthen its portfolio for cancer genomic profiling. These new developments will be showcased at the American ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of ...

For almost 60 years, measuring cholesterol levels in the blood has been the best way to identify individuals at high risk of ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

A blood test developed by researchers from Stanford (Calif.) Medicine is capable of detecting cancer and identifying how cancers might resist treatment. Here are four things to know about the test: ...

A new blood test that uses AI to detect signs of a dozen cancers long before symptoms develop is to be tested on NHS patients. The trial on 8,000 patients will analyse blood samples for tiny ...

A blood test that can detect cancer before symptoms develop is being assessed for potential NHS use, health officials have said. Health Secretary Wes Streeting will announce that the Government is ...

A blood test that can detect cancer before symptoms develop is being assessed for potential NHS use, health officials have said. Health Secretary Wes Streeting will announce that the Government is ...